Overexpression of PAX5 in oral carcinogenesis

Oncology Reports

Volumn 16, Issue 5, 2006, Pages 1003-1008

  Norhany, Sufi ^a   Kouzu, Yukinao ^a   Uzawa, Katsuhiro ^a   Hayama, Masayo ^a   Higo, Morihiro ^a   Koike, Hirofumi ^a   Kasamatu, Atsushi ^a   Tanzawa, Hideki ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Oral squamous cell carcinoma; PAX5; Real time quantitative RT PCR; Western blot

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR PAX5;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL TRANSFORMATION; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; B-CELL-SPECIFIC ACTIVATOR PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RNA, MESSENGER;

EID: 34548158223     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.5.1003     Document Type: Article

References (21)

1. Lippman SM, Sudbo J and Hong WK: Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23: 346-356, 2005. (Pubitemid 46206883)
2. Chi N and Epstein JA: Getting your Pax straight: Pax proteins in development and disease. Trends Genet 18: 41-47, 2002. (Pubitemid 34031857)
3. Adams B, Dorfler P, Aguzzi A, Kozmik Z, Maurer-Fogy I, Urbanek P and Busslinger M: Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS and adult testis. Genes Dev 6: 1589-1607, 1992.
4. Schafer BW: Emerging roles for PAX transcription factors in cancer biology. Gen Physiol Biophys 17: 211-224, 1998.
5. Baumann Kubetzko FB, Di Paolo C, Maag C, Meier R, Schafer BW, Betts DR, Stahel RA and Himmelmann A: The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis 25: 1839-1846, 2004. (Pubitemid 39405902)
6. Kozmik Z, Sure U, Ruedi D, Busslinger M and Aguzzi A: Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92: 5709-5713, 1995.
7. Krenacs L, Himmelmann AW, Quintanilla-Martinez L, Fest T, Riva A, Wellmann A, Bagdi E, Kehrl JH, Jaffe ES and Raffeld M: Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood 92: 1308-1316, 1998. (Pubitemid 28369044)
8. Scholl FA, Kamarashev J, Murmann OV, Geertsen R, Dummer R and Schafer BW: PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res 61: 823-826, 2001. (Pubitemid 32174385)
9. Koike H, Uzawa K, Nakashima D, Shimada K, Kato Y, Higo M, Kouzu Y, Endo Y, Kasamatsu A and Tanzawa H: Identification of differentially expressed proteins in oral squamous-cell carcinoma using a global proteomic approach. Int J Oncol 27: 59-67, 2005.
10. Busslinger M and Urbanek P: The role of BSAP (Pax-5) in B-cell development. Curr Opin Genet Dev 5: 595-601, 1995.
11. Tiacci E, Pileri S, Orleth A, Pacini R, Tabarrini A, Frenguelli F, Liso A, Diverio D, Lo-Coco F and Falini B: PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia. Cancer Res 64: 7399-7404, 2004. (Pubitemid 39372080)
12. Chalepakis G, Tremblay P and Gruss P: PAX genes, mutants and molecular function. J Cell Sci 16 (Suppl): 61-67, 1992. (Pubitemid 23097471)
13. Stuart ET and Gruss P: PAX: developmental control genes in cell growth and differentiation. Cell Growth Differ 7: 405-412, 1996. (Pubitemid 26360779)
14. Zhang X, Lin Z and Kim I: Pax5 expression in non-Hodgkin's lymphomas and acute leukemias. J Korean Med Sci 18: 804-808, 2003. (Pubitemid 38072929)
15. Adshead JM, Ogden CW, Penny MA, Stuart ET and Kessling AM: The expression of PAX5 in human transitional cell carcinoma of the bladder: relationship with the dedifferentiation. BJU Int 83: 1039-1044, 1999. (Pubitemid 29271876)
16. Palmisano WA, Crume KP, Grimes MJ, Winters SA, Toyota M, Esteller M, Joste N, Baylin SB and Belinsky SA: Aberrant promoter methylation of the transcription factor genes PAX5 α and β in human cancers. Cancer Res 63: 4620-4625, 2003. (Pubitemid 36951039)
17. Stuart ET, Kioussi C, Aguzzi A and Gruss P: PAX5 expression correlates with increasing malignancy in human astrocytomas. Clin Cancer Res 1: 207-214, 1995.
18. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
19. Stuart ET, Haffner R, Oren M and Gruss P: Loss of p53 functions through PAX-mediated transcriptional repression. EMBO J 14: 5638-5645, 1995.
20. Babjuk M, Soukup, V, Mares, Duskova J, Sedlácek Z, Trková M, Pecen L, Dvoracek J, Hanus T, Kocvara R, Novak J and Povysil C: The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome. Int Urol Nephrol 34: 495-501, 2002. (Pubitemid 37235974)
21. Slaughter DL, Southwick HW and Smejkal W: Field cancerization in oral stratified squamous epithelium. Cancer 6: 963-968, 1953.